Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.800 | None | 0.944 | 5 | 0 | 1989 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.833 | 1 | 1 | 2007 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.974 | 33 | 1 | 1990 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.600 | None | 0.983 | 7 | 0 | 1988 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.600 | None | 0.959 | 2 | 0 | 1994 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.600 | None | 0.839 | 1 | 0 | 1998 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.600 | None | 0.947 | 1 | 0 | 2005 | 2019 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.600 | None | 1.000 | 1 | 1 | 2003 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 2002 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.600 | None | 0.967 | 0 | 0 | 2002 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.550 | None | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.530 | None | 1.000 | 1 | 2 | 1994 | 2005 | ||||||||
|
protein phosphatase 2 scaffold subunit Abeta | 0.678 | 0.423 | 3.0E-15 |
|
disease | 0.520 | None | 1.000 | 0 | 3 | 1999 | 1999 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.500 | None | 0.978 | 3 | 2 | 2008 | 2019 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.500 | None | 0.958 | 2 | 2 | 1999 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 1 | 7 | 2008 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.500 | None | 0.934 | 1 | 2 | 2008 | 2018 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.500 | None | 1.000 | 1 | 13 | 2008 | 2018 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2000 | 2017 | ||||||||
|
solute carrier family 22 member 18 | 0.595 | 0.692 | 6.5E-06 |
|
disease | 0.500 | None | 0 | 0 | |||||||||||
|
flap structure-specific endonuclease 1 | 0.550 | 0.731 | 4.8E-05 |
|
disease | 0.490 | None | 0.800 | 1 | 1 | 2003 | 2019 | ||||||||
|
RAD52 homolog, DNA repair protein | 0.610 | 0.654 | 7.1E-11 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily A member 6 | 0.556 | 0.731 | 5.4E-09 |
|
disease | 0.400 | None | 0.868 | 6 | 0 | 1999 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.400 | None | 0.966 | 5 | 0 | 1986 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | None | 0.953 | 4 | 0 | 1994 | 2020 |